Literature DB >> 7527691

Rapid progression of multiple myeloma following G-CSF mobilization.

J de la Rubia1, S Bonanad, J Palau, G F Sanz, M A Sanz.   

Abstract

A 23-year-old man diagnosed as having multiple myeloma was treated with melphalan and prednisone monthly. After six cycles, an autologous peripheral blood stem cell transplantation (ABSCT) was planned. Peripheral blood mononuclear cells were collected after G-CSF mobilization (5 micrograms/kg/day for 5 days). Ten days after the last dose of G-CSF the patient showed a striking progression of multiple myeloma. A 57% infiltration of plasma cells in bone marrow and recurrence of laboratory abnormalities were evident. The patient's clinical course strongly suggests that myeloma progression was triggered by G-CSF and supports the concept of G-CSF mediated autocrine stimulation of myeloma growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527691

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.

Authors:  N Raje; R Powles; C Horton; B Millar; V Shepherd; G Middleton; S Kulkarni; T Eisen; J Mehta; S Singhal; J Treleaven
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Cancer incidence in healthy Swedish peripheral blood stem cell donors.

Authors:  Simon Pahnke; Ulla Axdorph Nygell; Jan-Erik Johansson; Annika Kisch; Per Ljungman; Anna Sandstedt; Hans Hägglund; Gunnar Larfors
Journal:  Bone Marrow Transplant       Date:  2022-03-07       Impact factor: 5.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.